Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,090 DKK | 0.00% | +8.46% | -18.05% |
03-27 | Orphazyme A/S Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-04 | FDA Extends Review of Zevra's Arimoclomol by Three Months | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-18.05% | 5.51M | |
-3.01% | 103B | |
+1.23% | 95.28B | |
+1.46% | 22.15B | |
-16.10% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.47% | 16.05B | |
+4.76% | 13.68B | |
+32.74% | 12.17B |
- Stock Market
- Equities
- ORPHA Stock
- News Orphazyme A/S
- Orphazyme A/S : To Cut Jobs After US Watchdog Rejects Rare Genetic Disorder Drug